Home / Indication Insights / Epidemiology Insights / Hereditary Angioedema - Epidemiology Forecast to 2025
Hereditary Angioedema - Epidemiology Forecast to 2025
Date: Dec, 2017
Type: Pharmaceutical Industry Report
Pages: 40
Geography: Global
Delivery Timeline: 48 hours
SKU: DIEI0065
DelveInsight's "Hereditary Angioedema -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Hereditary Angioedema in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Insulin Resistance. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Insulin Resistance. The report contains the targeted patient populations and the forecast methodology.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.
Key Coverage and Benefits
• The Report includes the prevalent population and how will it change over the next eight years.
• Coverage of key Hereditary Angioedema sub-populations and its prevalent or incident cases
• Prevalent or incident cases segmented by age and sex.
• The key differences in epidemiology patterns across the seven market segments.
Reasons to buy
• Developing business strategies by understanding the trends shaping and driving the global Hereditary Angioedema market.
• Identifying prevalent patient populations as well as risk factors in the global Hereditary Angioedema market will help to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Hereditary Angioedema therapeutics in each of the markets covered.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.
Key Coverage and Benefits
• The Report includes the prevalent population and how will it change over the next eight years.
• Coverage of key Hereditary Angioedema sub-populations and its prevalent or incident cases
• Prevalent or incident cases segmented by age and sex.
• The key differences in epidemiology patterns across the seven market segments.
Reasons to buy
• Developing business strategies by understanding the trends shaping and driving the global Hereditary Angioedema market.
• Identifying prevalent patient populations as well as risk factors in the global Hereditary Angioedema market will help to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Hereditary Angioedema therapeutics in each of the markets covered.
1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
• Key Findings
4. Hereditary Angioedema Overview
• Hereditary Angioedema Definition
• Pathophysiology
• Symptoms
• Etiology
5. Risk Factors Associated with Hereditary Angioedema
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
• Key Findings
• Key Sources used and Forecast Methodology
• Prevalent Cases and Incident Cases-2015-2025
• Prevalent & Incident Cases by Category-2015-2025
• Age-Specific Prevalent/ Incident Cases of Hereditary Angioedema
• Sex-Specific Prevalent/Incident Cases of Hereditary Angioedema
• Disease Type Specific Prevalent/Incident Cases of Hereditary Angioedema
8.Prevalent & Incident Cases by 7 MM-2015-2025
• Hereditary Angioedema Epidemiology of United States-2025
• Hereditary Angioedema Epidemiology of United Kingdom-2025
• Hereditary Angioedema Epidemiology of Germany-2025
• Hereditary Angioedema Epidemiology of France-2025
• Hereditary Angioedema Epidemiology of Spain-2025
• Hereditary Angioedema Epidemiology of Italy-2025
• Hereditary Angioedema Epidemiology of Japan-2025
9. Key Takeaways
10. Appendix
11.Report Methodology
12. Consulting Services
13. Disclaimer
14. About Us
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
• Key Findings
4. Hereditary Angioedema Overview
• Hereditary Angioedema Definition
• Pathophysiology
• Symptoms
• Etiology
5. Risk Factors Associated with Hereditary Angioedema
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
• Key Findings
• Key Sources used and Forecast Methodology
• Prevalent Cases and Incident Cases-2015-2025
• Prevalent & Incident Cases by Category-2015-2025
• Age-Specific Prevalent/ Incident Cases of Hereditary Angioedema
• Sex-Specific Prevalent/Incident Cases of Hereditary Angioedema
• Disease Type Specific Prevalent/Incident Cases of Hereditary Angioedema
8.Prevalent & Incident Cases by 7 MM-2015-2025
• Hereditary Angioedema Epidemiology of United States-2025
• Hereditary Angioedema Epidemiology of United Kingdom-2025
• Hereditary Angioedema Epidemiology of Germany-2025
• Hereditary Angioedema Epidemiology of France-2025
• Hereditary Angioedema Epidemiology of Spain-2025
• Hereditary Angioedema Epidemiology of Italy-2025
• Hereditary Angioedema Epidemiology of Japan-2025
9. Key Takeaways
10. Appendix
11.Report Methodology
12. Consulting Services
13. Disclaimer
14. About Us
Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Hereditary Angioedema Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Hereditary Angioedema Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Hereditary Angioedema Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Hereditary Angioedema Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Hereditary Angioedema Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Hereditary Angioedema Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Hereditary Angioedema Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Hereditary Angioedema Sub-population, Japan (2015-2025)
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Hereditary Angioedema Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Hereditary Angioedema Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Hereditary Angioedema Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Hereditary Angioedema Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Hereditary Angioedema Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Hereditary Angioedema Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Hereditary Angioedema Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Hereditary Angioedema Sub-population, Japan (2015-2025)
Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Hereditary Angioedema Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Hereditary Angioedema Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Hereditary Angioedema Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Hereditary Angioedema Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Hereditary Angioedema Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Hereditary Angioedema Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Hereditary Angioedema Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Hereditary Angioedema Sub-population,Japan (2015-2025)
Figure 2: Sources used for forecasting the data
Figure 3: Hereditary Angioedema Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Hereditary Angioedema Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Hereditary Angioedema Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Hereditary Angioedema Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Hereditary Angioedema Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Hereditary Angioedema Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Hereditary Angioedema Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Hereditary Angioedema (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Hereditary Angioedema By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Hereditary Angioedema Sub-population,Japan (2015-2025)
Hereditary Angioedema Disease Overview
Hereditary Angioedema Prevalence
Hereditary Angioedema Incidence
Hereditary Angioedema Risk Factors
Hereditary Angioedema Epidemiology
Hereditary Angioedema Patient Populations
Hereditary Angioedema Diagnosed Patients
Hereditary Angioedema Forecast
Hereditary Angioedema Epidemiology Forecast
Hereditary Angioedema Treated patients/population
Hereditary Angioedema Prevalence
Hereditary Angioedema Incidence
Hereditary Angioedema Risk Factors
Hereditary Angioedema Epidemiology
Hereditary Angioedema Patient Populations
Hereditary Angioedema Diagnosed Patients
Hereditary Angioedema Forecast
Hereditary Angioedema Epidemiology Forecast
Hereditary Angioedema Treated patients/population
